Freescale to keep Sendai plant closed

Apr 06, 2011

Freescale Semiconductor has decided against reopening its plant in Sendai after the massive earthquake and tsunami in northeastern Japan left it severely damaged.

The plant, which has 600 employees, had been due to be shuttered in December.

"The ongoing safety concerns, damage to infrastructure and other basic services in the region, compounded by numerous major aftershocks, prohibit Freescale from returning the facility to an operational level required for wafer fab production in a reasonable timeframe," the company said in a statement Tuesday.

It had immediately ceased operations after the earthquake struck off the coast of Sendai, and evacuated its employees.

Rich Beyer, Freescale's chairman and CEO, said the company would compensate its Sendai employees by continuing their salaries "for an extended period of time," along with a "comprehensive" severance package.

The Sendai facility produced microcontrollers, analog ICs () and sensors products.

Built in 1987, it was originally conceived as a joint venture of Toshiba and . Motorola's Semiconductor Products Sector, now Freescale, purchased the plant in 1999.

Explore further: Yahoo! to buy blog-maker Tumblr for $1.1 bn (Update)

add to favorites email to friend print save as pdf

Related Stories

Samsung Opens Largest Wafer Plant In Austin, Texas

Jun 15, 2007

Samsung Electronics announced the opening of the largest 300mm NAND flash memory wafer plant in Austin, Texas on Thursday, in ceremonies that included Texas Governor Rick Perry and Samsung Electronics Vice ...

Recommended for you

Panel says Apple uses firms outside US to avoid taxes (Update)

52 minutes ago

The world's most valuable company, Apple Inc., employs a group of affiliate companies located in Ireland to avoid paying billions of dollars in U.S. income taxes, a Senate investigation has found—and its CEO will be questioned ...

Actavis buying Warner Chilcott in $8.5B deal

9 hours ago

Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.

User comments : 0

More news stories

UC Davis startup changes listening experience

Fifteen years of research at the University of California, Davis, is being turned into commercial products by Dysonics, a startup company based in San Francisco. Since becoming the first "graduate" from the Engineering Translational ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...